A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response-Reference-Cited by-同舟云学术

A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response

Published:2009-09-28 Issue:41 Volume:48 Page:7551-7555
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Kaiser Anton,Gaidzik Nikola,Westerlind Ulrika,Kowalczyk Danuta,Hobel Alexandra,Schmitt Edgar,Kunz Horst

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/anie.200902564/fullpdf

Reference63 articles.

1. A synthetic vaccine constructed by copolymerization of B and T cell determinants

2. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

3. Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activation

4. Synthetic Vaccines: The Role of Adjuvants in Immune Targeting

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy;Journal of Controlled Release;2024-03

2. Synthetic self‐adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy;MedComm;2024-02

3. Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines;Biotechnology Advances;2023-07

4. Glycoproteins and Cancer Biomarkers;Current Cancer Biomarkers;2023-01

5. Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics;Pharmacology & Therapeutics;2022-07